4.5 Review

An Update on Extemporaneous Preparation of Radiopharmaceuticals Using Freeze-Dried Cold Kits

Journal

MINI-REVIEWS IN MEDICINAL CHEMISTRY
Volume 21, Issue 11, Pages 1322-1336

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389557520999201214233634

Keywords

Radiopharmaceuticals; diagnostic radiopharmaceuticals; therapeutic radiopharmaceuticals; cold kits; Ga-68 radiopharmaceuticals; Lu-177 radiopharmaceuticals

Ask authors/readers for more resources

The field of nuclear medicine is rapidly evolving due to the high demand for radiopharmaceuticals for diagnostic and therapeutic applications. Kit formulations simplify the preparation of radiopharmaceuticals, enabling extensive applications of various isotopes for imaging and therapy.
The field of nuclear medicine is rapidly evolving due to the high demand of radiopharmaceuticals for diagnostic and therapeutic applications. The availability of a vast array of radioisotopes, improvement in radiolabeling strategies, and advancements in detection systems have also contributed to the progress in this field. Radiopharmaceuticals are mainly classified based on their application as diagnostic or therapeutic radiopharmaceuticals. These are available either as ready to use preparations or prepared at hospital radiopharmacy either using automated synthesis modules or by using freeze-dried cold kit formulations. Availability of freeze-dried cold kits for preparation of varied radiopharmaceuticals for targeting various organs and tumors played an essential role in the extensive use of Tc-99m radiopharmaceuticals for diagnostic imaging by single-photon emission computed tomography (SPECT) imaging. Cold kits are especially suitable for the preparation of radiopharmaceuticals labeled with isotopes like Lu-177 with relatively long half-life or radionuclides produced by radioisotope generators. A simplified procedure for the preparation of positron emission tomography (PET) radiopharmaceuticals is also desired to achieve images with higher resolution and sensitivity offered by PET. Robust kit formulations will simplify the preparation of PET radiopharmaceuticals and will contribute to extensive applications of positron emitters such as Ga-68. Several therapeutic radiopharmaceuticals are also being made using cold kits of the ligands. This review provides an update on diagnostic and therapeutic radiopharmaceuticals prepared using cold kits.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available